On its discovery in 1965 by Gold and Freedman1 in the blood of patients with colorectal cancer, human carcinoembryonic antigen [CEA (since re-designated CEACAM5)] was initially thought to be a tumour-specific antigen. This evidence concerns the gene CEACAM5 and neoplasm.